Lisa D. Earnhardt - Mar 6, 2025 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role
EVP AND GROUP PRESIDENT
Signature
/s/ Lisa D. Earnhardt by Jessica H. Paik, Attorney-in-Fact
Stock symbol
ABT
Transactions as of
Mar 6, 2025
Transactions value $
-$4,828,397
Form type
4
Date filed
3/7/2025, 06:55 PM
Previous filing
Mar 4, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABT Common shares without par value Options Exercise $7.38M +91.2K +126.75% $80.98 163K Mar 6, 2025 Direct
transaction ABT Common shares without par value Sale -$12.2M -91.2K -55.9% $133.82 71.9K Mar 6, 2025 Direct
transaction ABT Common shares without par value Options Exercise $16.2K +200 +0.28% $80.98 72.1K Mar 7, 2025 Direct
transaction ABT Common shares without par value Sale -$27.3K -200 -0.28% $136.65 71.9K Mar 7, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABT Option (right to buy) Options Exercise $0 -91.2K -99.78% $0.00 200 Mar 6, 2025 Common shares 91.2K $80.98 Direct F1
transaction ABT Option (right to buy) Options Exercise $0 -200 -100% $0.00 0 Mar 7, 2025 Common shares 200 $80.98 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.